Figure 3
From: Quantitative evaluation of RASSF1Amethylation in the non-lesional, regenerative and neoplastic liver
Quantitative evaluation of RASSF1A methylation by Real-Time MSP. The median value of methylation index, 25 and 75% percentiles, and minimum ad maximum values detected in liver cirrhosis, hepatocellular nodules (HN) and hepatocellular carcinoma (HCC) is reported in panel A; the median value of methylation index, 25 and 75% percentiles, and minimum and maximum values detected in non-lesional liver (NLL), focal nodular hyperplasia (FNH) and hepatocellular adenoma (HA) is reported in panel B.